This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Nexbiome Therapeutics. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Virginie Busignies: Innovator in Mucoadhesive Drug Delivery Systems
Introduction
Virginie Busignies is a notable inventor based in Mérignac, France. She has made significant contributions to the field of pharmaceutical technology, particularly in the development of innovative drug delivery systems. Her work focuses on enhancing the effectiveness of treatments through advanced formulations.
Latest Patents
Virginie Busignies holds a patent for a mucoadhesive sustained-release vaginal tablet. This invention includes at least one probiotic strain of the genus, compressed with an excipient that confers properties of vaginal wall mucoadhesion and sustained release. This innovative approach aims to improve the delivery and efficacy of therapeutic agents in women's health.
Career Highlights
Busignies is currently associated with Nexbiome Therapeutics, where she continues to advance her research and development efforts. Her work is pivotal in creating solutions that address specific health needs, particularly in the area of vaginal health.
Collaborations
She collaborates with esteemed colleagues, including Claudia Thoral and Pierre Tchoreloff, who contribute to her research initiatives and help drive innovation within the company.
Conclusion
Virginie Busignies exemplifies the spirit of innovation in the pharmaceutical industry, with her groundbreaking work on mucoadhesive drug delivery systems. Her contributions are set to make a lasting impact on women's health treatments.